We’re looking forward to seeing you in Orlando, Florida, for the HealthTrust University Conference. From August 12-13 we’ll be sharing about oncology solutions at booth #1024.
NeoGenomics Laboratories’ Post
More Relevant Posts
-
Today’s FDA approval marks a pivotal achievement in our ongoing collaboration with patients, advocates, medical professionals and researchers to help address concerns around disease recurrence in #earlybreastcancer. As we celebrate this new milestone in our 35-year long journey to address the needs of people touched by breast cancer, we reflect on the personal and collective drivers behind our work in this space. Take a look at our sources of inspiration and share with us: what fuels your efforts in #breastcancer? #bcsm #ReimaginingMedicine, together
What inspires our efforts in breast cancer?
To view or add a comment, sign in
-
Are you a leader at a patient organization? If so, you won’t want to miss the third installment of our five-part Patient Organization Webinar Series. Join fellow leaders for Changing Oncology Landscape: Considerations for Oncology Organizations and Registries. 📅 Wednesday, June 26, 2024, 11:00 AM EDT 📌 Webinar 🎙️ Audra Moran, Kapila Viges, Jeff Hodge, Murray Aitken 🔗 Register here: https://lnkd.in/ehRnEdkj #PatientAdvocacy #PatientOutcomes
To view or add a comment, sign in
-
The rapid evolution of cancer care creates many challenges for providers. From navigating new technology deployment, to #staffing shortages, and rising care costs - Varian's Advanced Oncology Solutions is your trusted partner. Our subject matter experts bring a holistic approach to optimizing and standardizing your clinical operations and workflows so you can plan for the future while addressing today’s challenges. Visit us at #ESTRO24 to learn more.
Varian AOS at #ESTRO24
To view or add a comment, sign in
-
The recent Supreme Court decision to overturn Chevron deference could reshape how the FDA regulates cancer treatments, shifting critical decisions from agency experts to the courts. In my Friends of Cancer Research commentary and video, I explore how this ruling may impact patient access to innovative therapies, increase legal challenges to FDA decisions, and slow down critical regulatory advancements. #FDA #HealthcarePolicy #CancerResearch #SupremeCourt #ChevronDeference
Overturning of the Chevron deference by the SCOTUS— what does it all mean? Our VP of public affairs, Ryan Hohman, delves into the implications this ruling has for the FDA and patient access to innovative #cancer therapies. Read the full Q&A with Ryan: https://lnkd.in/e7iz9uwG Can’t view video? Watch on YouTube: https://lnkd.in/etuhxZDU
To view or add a comment, sign in
-
Drug revenue is projected to account for 90% of the average practice's total revenue in 2023, according to our estimates. Drop a note below if you are interested in accessing more in-depth analysis of the significance of cancer drug revenues in community practices. https://okt.to/zv3JX8 #marketaccess #communityoncology #marketaccessinsights #drugrevenuetrends
To view or add a comment, sign in
-
Strategic marketing leader who delivers insight-led strategies and outcomes for patients and stakeholders who serve them.
Thank you, Stacy Hurt, for helping us all at Parexel stay laser-focused on our North Star—the patients! Your relentless passion for representing the patient perspective has been an inspiration since day one of my journey at Parexel. I'm deeply grateful for your support and significant contributions to our latest New Medicines Novel Insights report! 🔑 "The key to advancing precision oncology is to democratize the data." 🔑 Stacy Hurt, Parexel's Chief Patient Officer and a stage 4 cancer survivor, highlights three things we MUST do to ensure all patients can potentially benefit from precision oncology in our New Medicines, Novel Insights report: https://lnkd.in/gJWamVHP #PatientData #Oncology #patientsfirst #NovelInsights
To view or add a comment, sign in
-
Thank you to those on my feed who reminded me of #NationalPetDay. Everyone meet Luna. Her favorite thing is co-marketing the solid tumor GDUs! 🙂 Shameless plug from Luna: “Check out our upcoming debates calendar! Mark your calendars & get ready to elevate your knowledge and expertise in the field of oncology & secure free registration for clinicians. ➡️ greatdebatesandupdates.com”
To view or add a comment, sign in
-
Attending the 16th Annual AACI (Association of American Cancer Institutes) CRI Meeting in Rosemont next week? Come visit the RealTime team to learn more about how our family of brands and products, including Devana's category-defining PROPEL platform, can help transform your clinical trial process from start to finish! #clinicaltrials #clinicalresearch #clinicaltrialsoftware #PROPEL
To view or add a comment, sign in
-
“What would you do if your doctor told you they knew how to treat your cancer, but couldn't get the medicine to do so?” 😳 In the war against drug shortages, everyone who can, should play a role. And among those players, is the clinical supply chain industry. The facts are: 1. Over 6,000 ongoing trials use one of the 14 𝐨𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐝𝐫𝐮𝐠𝐬 listed as being in 𝐬𝐡𝐨𝐫𝐭𝐚𝐠𝐞 by the FDA (as of June 6, 2024). 2. 𝐃𝐫𝐮𝐠 𝐰𝐚𝐬𝐭𝐞 in oncology chemotherapies and co-medications was estimated by our benchmarks to be 𝐛𝐞𝐭𝐰𝐞𝐞𝐧 70% 𝐚𝐧𝐝 80% in clinical trials. 3. If that number were 40% instead, we would reduce by half the amount of oncology drugs used in clinical trials, potentially 𝐬𝐚𝐯𝐢𝐧𝐠 𝐰𝐡𝐨 𝐤𝐧𝐨𝐰𝐬 𝐡𝐨𝐰 𝐦𝐚𝐧𝐲 𝐥𝐢𝐯𝐞𝐬. For over 20 years, N-SIDE has been advocating for waste reduction in the clinical supply chain. And making it happen successfully - it is our specialty. We invite any company with a planned or ongoing trial using one of these drugs to reach out to us so we can help re-inject some of these treatments into the market. Waste reduction is not a financial question, it’s an 𝐞𝐭𝐡𝐢𝐜𝐚𝐥 𝐪𝐮𝐞𝐬𝐭𝐢𝐨𝐧. Let’s do it for the patients! 💪
Our members see first-hand how cancer #drugshortages harm patients when they have to share difficult news about not having access to common, essential treatments that are in shortage. “It’s heartbreaking,” shares ASCO member Ashley Sumrall, MD, FACP, FASCO. Sign our Open Letter to stand with oncology professionals and urge Congress and the administration to act now to end this crisis: https://brnw.ch/21wKokP #ASCOAdvocacy #ASCO24
Drug Shortages: A Crisis for Cancer Care
To view or add a comment, sign in
-
Enrol in our comprehensive Oncology Course Activities and Resources! Access your syllabus, resources, slide decks, quizzes, and both participant and PowerPoint workbooks. Everything you need to succeed is just a click away! 💡 For more information on the oncology course, visit: https://lnkd.in/dDTP7Gsq #OncologyEducation #HealthcareHeroes #FreeCourse #CancerCare #NursingExcellence #SouthAfricanHealthcare #CourseResources #LearningTools #StudySmart
To view or add a comment, sign in
33,399 followers